SEARCH

SEARCH BY CITATION

References

  • Aarts M., Liu Y., Liu L., Besshoh S., Arundine M., Gurd J. W., Wang Y. T., Salter M. W. and Tymianski M. (2002) Treatment of ischemic brain damage by perturbing NMDA receptor – PSD-95 protein interactions. Science 298, 846.
  • Arai K., Ikegaya Y., Nakatani Y., Kudo I., Nishiyama N. and Matsuki N. (2001) Phospholipase A2 mediates ischemic injury in the hippocampus: a regional difference of neuronal vulnerability. Eur. J. Neurosci. 13, 2319.
  • Banik N. L., Matzelle D., Terry E., Gantt-Wilford G. and Hogan E. L. (2000) Inhibition of proteolysis by a cyclooxygenase inhibitor, indomethacin. Neurochem. Res. 25, 1509.
  • Benchoua A., Braudeau J., Reis A., Couriaud C. and Onteniente B. (2004) Activation of proinflammatory caspases by cathepsin B in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 24, 1272.
  • Benov L., Sztejnberg L. and Fridovich I. (1998) Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Rad. Biol. Med. 25, 826.
  • Bivik C. A., Larsson P. K., Kagedal K. M., Rosdahl I. K. and Ollinger K. M. (2006) UVA/B-induced apoptosis in human melanocytes involves translocation of cathepsins and Bcl-2 family members. J. Invest. Dermatol. 126, 1119.
  • Chan P. H., Kawase M., Murakami K., Chen S. F., Li Y., Calagui B., Reola L., Carlson E. and Epstein C. J. (1998) Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J. Neurosci. 18, 8292.
  • Chen J., Nagayama T., Jin K., Stetler R. A., Zhu R. L., Graham S. H. and Simon R. P. (1998) Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18, 4914.
  • Chu C. T., Levinthal D. J., Kulich S. M., Chalovich E. M. and DeFranco D. B. (2004) Oxidative neuronal injury. The dark side of ERK1/2. Eur. J. Biochem. 271, 2060.
  • Dogan A., Rao A. M., Baskaya M. K., Rao V. L., Rastl J., Donaldson D. and Dempsey R. J. (1997) Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia. J. Neurosurg. 87, 921.
  • De Duve C. (2005) The lysosome turns fifty. Nat. Cell Biol. 7, 847.
  • Feig S. and Lipton P. (1990) N-methyl-D-aspartate receptor activation and Ca2+ account for poor pyramidal cell structure in hippocampal slices. J. Neurochem. 55, 473.
  • Feig S. and Lipton P. (1993) Pairing the cholinergic agonist carbachol with patterned Schaffer collateral stimulation initiates protein synthesis in hippocampal CA1 pyramidal cell dendrites via a muscarinic, NMDA-dependent mechanism. J. Neurosci. 13, 1010.
  • Foghsgaard L., Wissing D., Mauch D., Lademann U., Bastholm L., Boes M., Elling F., Leist M. and Jaattela M. (2001) Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153, 999.
  • Frantseva M. V., Carlen P. L. and Perez Velazquez J. L. (2001) Dynamics of intracellular calcium and free radical production during ischemia in pyramidal neurons. Free Rad. Biol. Med. 31, 1216.
  • Gieselmann V., Hasilik A. and Von Figura K. (1985) Processing of human cathepsin D in lysosomes in vitro. J. Biol. Chem. 260, 3215.
  • Gijon M. A., Spencer D. M., Kaiser A. L. and Leslie C. C. (1999) Role of phosphorylation sites and the C2 domain in regulation of cytosolic phospholipase A2. J. Cell Biol. 145, 1219.
  • Goldstein P. and Kroemer G. (2007) Cell death by necrosis: towards a molecular definition. Trends Biochem. Sci. 32, 37.
  • Guicciardi M. E., Deussing J., Miyoshi H., Bronk S., Svingen P., Peters C., Kaufmann S. and Gores G. (2000) Cathepsin B contributes to TNF alpha mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106, 1127.
  • Hong S. C., Goto Y., Lanzino G., Soleau S., Kassell N. F. and Lee K. S. (1994) Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 25, 663.
  • Iadecola C., Niwa K., Nogawa S., Zhao X., Nagayama M., Araki E., Morham S. and Ross M. E. (2001) Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl Acad. Sci. USA 98, 1294.
  • Inuzuka T., Tamura A., Sato S., Kirino T., Yanagisawa K., Toyoshima I. and Miyatake T. (1990) Changes in the concentrations of cerebral proteins following occlusion of the middle cerebral artery in rats. Stroke 21, 917.
  • Ivanov A., Pellegrino C., Rama S., Dumalska I., Salyha Y., Ben Ari Y. and Medina I. (2006) Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons. J. Physiol. 572, 789.
  • Johansson A. C., Steen H., Ollinger K. and Roberg K. (2003) Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ. 10, 1253.
  • Kagedal K., Johansson U. and Ollinger K. (2001) The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J. 15, 1592.
  • Kaku D. A., Giffard R. G. and Choi D. W. (1993) Neuroprotective effects of glutamate antagonists and extracellular acidity. Science 260, 1516.
  • Kirino T., Tamura A. and Sano K. (1984) Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol. 64, 139.
  • Krapivinsky G., Krapivinsky L., Manasian Y., Ivanov A., Tyzio R., Pellegrino C., Ben Ari Y., Clapham D. E. and Medina I. (2003) The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. Neuron 40, 775.
  • Kukreja R. C., Kontos H. A., Hess M. L. and Ellis E. F. (1986) PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ. Res. 59, 612.
  • Kunz A., Anrather J., Zhou P., Orio M. and Iadecola C. (2006) Cyclooxygenase-2 does not contribute to postischemic production of reactive oxygen species. J. Cereb. Blood Flow Metab. 27, 545551.
  • Kurz T., Gustafsson B. and Brunk U. T. (2006) Intralysosomal iron chelation protects against oxidative stress-induced cellular damage. FEBS J. 273, 3106.
  • Lazarewicz J. W., Salinska E. and Wroblewski J. T. (1992) NMDA receptor-mediated arachidonic acid release in neurons: role in signal transduction and pathological aspects. Adv. Exp. Med. Biol. 318, 73.
  • Li P. A., Howlett W., He Q. P., Miyashita H., Siddiqui M. and Shuaib A. (1998) Postischemic treatment with calpain inhibitor MDL 28170 ameliorates brain damage in a gerbil model of global ischemia. Neuro Lett. 247, 17.
  • Lio Y. C., Reynolds L. J., Balsinde J. and Dennis E. A. (1996) Irreversible inhibition of Ca(2+)-independent phospholipase A2 by methyl arachidonyl fluorophosphonate. Biochim. Biophys. Acta 1302, 5560.
  • Lipton P. (1999) Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431.
  • Lobner D. and Lipton P. (1993) Intracellular calcium levels and calcium fluxes in the CA1 region of the rat hippocampal slice during in vitro ischemia: relationship to electrophysiological cell damage. J. Neurosci. 13, 4861.
  • Lucas K. K. and Dennis E. A. (2005) Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors. Prostaglandins Other Lipid Mediat. 77, 235248.
  • Luke C. J., Pak S. C., Askew Y. S. et al. (2007) An intracellular serpin regulates necrosis by inhibiting the induction and sequelae of lysosomal injury. Cell 130, 1108.
  • Mach L., Schwihla H., Stuwe K., Rowan A. D., Mort J. S. and Glossl J. (1993) Activation of procathepsin B in human hepatoma cells: the conversion into the mature enzyme relies on the action of cathepsin B itself. Biochem. J. 293, 437.
  • Mak I. T., Misra H. P. and Weglicki W. B. (1983) Temporal relationship of free radical-induced lipid peroxidation and loss of latent enzyme activity in highly enriched hepatic lysosomes. J. Biol. Chem. 258, 13733.
  • Martin L. J., Al-Abdulla N. A., Brambrink A. M., Kirsch J. R., Sieber F. E. and Portera-Cailliau C. (1998) Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 46, 281309.
  • McBean D. E., Winters V., Wilson A. D., Oswald C. B., Alps B. J. and Armstrong J. M. (1995) Neuroprotective efficacy of lifarizine (RS-87476) in a simplified rat survival model of 2 vessel occlusion. Br. J. Pharmcol. 116, 3093.
  • McManus T., Sadgrove M., Pringle A. K., Chad J. E. and Sundstrom L. E. (2004) Intraischaemic hypothermia reduces free radical production and protects against ischaemic insults in cultured hippocampal slices. J. Neurochem. 91, 327.
  • Minger S. L., Geddes J. W., Holtz M. L., Craddock S. D., Whiteheart S. W., Siman R. G. and Pettigrew L. C. (1998) Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia. Brain Res. 810, 181.
  • Monje M. L., Chatten-Brown J., Hye S. E. and Raley-Susman K. M. (2000) Free radicals are involved in the damage to protein synthesis after anoxia/aglycemia and NMDA exposure. Brain Res. 857, 172.
  • Mrsic-Pelcic J., Zupan G., Maysinger D., Pelcic G., Vitezic D. and Simonic A. (2002) The influence of MK-801 on the hippocampal free arachidonic acid level and Na+,K+-ATPase activity in global cerebral ischemia-exposed rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 26, 1319.
  • Muralikrishna A. R. and Hatcher J. F. (2006) Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Rad. Biol. Med. 40, 376.
  • Nagayama M., Niwa K., Nagayama T., Ross M. E. and Iadecola C. (1999) The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene. J. Cereb. Blood Flow Metab. 19, 1213.
  • Nilsson C., Johansson U., Johansson A. C., Kagedal K. and Ollinger K. (2006) Cytosolic acidification and lysosomal alkalinization during TNF-alpha induced apoptosis in U937 cells. Apoptosis 11, 1149.
  • Ogata N., Yonekawa Y., Taki W., Kannagi R., Murachi T., Hamakubo T. and Kikuchi H. (1989) Degradation of neurofilament protein in cerebral ischemia. J. Neurosurg. 70, 103.
  • Ogburn K. D. and Figueiredo-Pereira M. E. (2006) Cytoskeleton/endoplasmic reticulum collapse induced by prostaglandin J2 parallels centrosomal deposition of ubiquitinated protein aggregates. J. Biol. Chem. 281, 23274.
  • Ollinger K. (2000) Inhibition of cathepsin D prevents free-radical-induced apoptosis in rat cardiomyocytes. Arch. Biochem. Biophys. 373, 346.
  • Olsson G. M., Svensson I., Zdolsek J. M. and Brunk U. T. (1989) Lysosomal enzyme leakage during the hypoxanthine/xanthine oxidase reaction. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 56, 385.
  • Pennacchio L. A., Lehesjoki A. E., Stone N. E. et al. (1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271, 1731.
  • Pepicelli O., Fedele E., Bonanno G., Raiteri M., Ajmone-Cat M. A., Greco A., Levi G. and Minghetti L. (2002) In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J. Neurochem. 81, 10281034.
  • Picconi B., Tortiglione A., Barone I. et al. (2006) NR2B subunit exerts a critical role in postischemic synaptic plasticity. Stroke 37, 1895.
  • Piqueras A. I., Somers M., Hammond T. G., Strange K., Harris H. W. Jr., Gawryl M. and Zeidel M. L. (1994) Permeability properties of rat renal lysosomes. Am. J. Physiol. 266, 121–133.
  • Raley-Susman K. M. and Lipton P. (1990) In vitro ischemia and protein synthesis in the rat hippocampal slice: the role of calcium and NMDA receptor activation. Brain Res. 515, 27.
  • Rashba-Step J., Tatoyan A., Duncan R., Ann D., Pushpa-Rehka T. R. and Sevanian A. (1997) Phospholipid peroxidation induces cytosolic phospholipase A2 activity: membrane effects versus enzyme phosphorylation. Arch. Biochem. Biophys. 343, 4454.
  • Roberg K., Kagedal K. and Ollinger K. (2002) Microinjection of cathepsin d induces caspase-dependent apoptosis in fibroblasts. Am. J. Pathol. 161, 89.
  • Schaloske R. H. and Dennis E. A. (2006) The phospholipase A2 superfamily and its group numbering system. Biochim. Biophys. Acta 1761, 12461259.
  • Seo S. R., Chong S. A., Lee S. I., Sung J. Y., Ahn Y. S., Chung K. C. and Seo J. T. (2001) Zn2+-induced ERK activation mediated by reactive oxygen species causes cell death in differentiated PC12 cells. J. Neurochem. 78, 600610.
  • Seyfried D., Han Y., Zheng Z., Day N., Moin K., Rempel S., Sloane B. and Chopp M. (1997) Cathepsin B and middle cerebral artery occlusion in the rat. J. Neurosurg. 87, 716.
  • Shen Y., Kishimoto K., Linden D. J. and Sapirstein A. (2007) Cytosolic phospholipase A(2) alpha mediates electrophysiologic responses of hippocampal pyramidal neurons to neurotoxic NMDA treatment. Proc. Natl Acad. Sci. USA 104, 60786083.
  • Sleat D. E., Zheng H., Qian M. and Lobel P. (2006) Identification of sites of mannose 6-phosphorylation on lysosomal proteins. Mol. Cell Proteomics 5, 686.
  • Smith M. L., Auer R. N. and Siesjo B. K. (1984) The density and distribution of ischemic brain injury in the rat following 2–10 min of forebrain ischemia. Acta Neuropathol. 64, 319.
  • Solenski N. J., Kwan A. L., Yanamoto H., Bennett J. P., Kassell N. F. and Lee K. S. (1997) Differential hydroxylation of salicylate in core and penumbra regions during focal reversible cerebral ischemia. Stroke 28, 2545.
  • Tabuchi S., Uozumi N., Ishii S., Shimizu Y., Watanabe T. and Shimizu T. (2003) Mice deficient in cytosolic phospholipase A2 are less susceptible to cerebral ischemia/reperfusion injury. Acta Neurochir. Suppl. 86, 169.
  • Tsubokawa T., Solaroglu I., Yatsushige H., Cahill J., Yata K. and Zhang J. H. (2006) Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats. Stroke 37, 1888.
  • Werneburg N. W., Guicciardi M. E., Bronk S. F. and Gores G. J. (2002) Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G947.
  • Xu J., Weng Y. I., Simonyi A., Krugh B. W., Liao Z., Weisman G. A. and Sun G. Y. (2002) Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes. J. Neurochem. 83, 259.
  • Yamashima T., Kohda Y., Tsuchiya K., Ueno T., Yamashita J., Yoshioka T. and Kominami E. (1998) Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on ‘calpain-cathepsin hypothesis’. Eur. J. Neurosci. 10, 1723.
  • Yamashima T., Tonchev A. B., Tsukada T., Saido T. C., Imajoh-Ohmi S., Momoi T. and Kominami E. (2003) Sustained calpain activation associated with lysosomal rupture executes necrosis of the postischemic CA1 neurons in primates. Hippocampus 13, 791.
  • Yonekura I., Kawahara N., Nakatomi H., Furuya K. and Kirino T. (2004) A model of global cerebral ischemia in C57 BL/6 mice. J. Cereb. Blood Flow Metab. 24, 151158.
  • Yoshida M., Yamashima T., Zhao L., Tsuchiya K., Kohda Y., Tonchev A. B., Matsuda M. and Kominami E. (2002) Primate neurons show different vulnerability to transient ischemia and response to cathepsin inhibition. Acta Neuropathol. 104, 267.
  • Zdolsek J., Zhang H., Roberg K. and Brunk U. (1993) H2O2-mediated damage to lysosomal membranes of J-774 cells. Free Rad. Res. Comm. 18, 71.
  • Zhang Y. and Lipton P. (1999) Cytosolic Ca2+ changes during in vitro ischemia in rat hippocampal slices: major roles for glutamate and Na+-dependent Ca2+ release from mitochondria. J. Neurosci. 19, 3307.
  • Zhang F., Liu C. L. and Hu B. R. (2006a) Irreversible aggregation of protein synthesis machinery after focal brain ischemia. J. Neurochem. 98, 102.
  • Zhang G., Yi Y. P. and Zhang G. J. (2006b) Effects of arachidonic acid on the lysosomal ion permeability and osmotic stability. J. Bioenerg. Biomembr. 38, 75.
  • Zhao M., Brunk U. T. and Eaton J. W. (2001) Delayed oxidant-induced cell death involves activation of phospholipase A2. FEBS Lett. 509, 399.
  • Zong W. X. and Thompson C. B. (2006) Necrotic death as a cell fate. Genes Dev. 20, 1.